C-Jun N-terminal kinases
| Identifiers | |
| Symbol | MAPK8 |
| Alt. Symbols | PRKM8 |
| Entrez | 5599 |
| HUGO | 6881 |
| OMIM | 601158 |
| RefSeq | NM_002750 |
| UniProt | P45983 |
| Other data | |
| Locus | Chr. 10 q11.2 |
| Identifiers | |
| Symbol | MAPK9 |
| Alt. Symbols | PRKM9 |
| Entrez | 5601 |
| HUGO | 6886 |
| OMIM | 602896 |
| RefSeq | NM_002752 |
| UniProt | P45984 |
| Other data | |
| Locus | Chr. 5 q35 |
| mitogen-activated protein kinase 10
| |
| Identifiers | |
| Symbol | MAPK10 |
| Alt. Symbols | PRKM10 |
| Entrez | 5602 |
| HUGO | 6872 |
| OMIM | 602897 |
| RefSeq | NM_002753 |
| UniProt | P53779 |
| Other data | |
| Locus | Chr. 4 q22-q23 |
Overview
C-Jun N-terminal kinases (JNKs), originally identified as kinases that bind and phosphosphorylate c-Jun on Ser63 and Ser73 within its transcriptional activation domain, are mitogen-activated protein kinases which are responsive to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock, and are involved in T cell differentiation and apoptosis.
Isoforms
The c-Jun N-terminal kinases consist of ten isoforms deriving from the three genes JNK1, JNK2 and JNK3[1]:
- JNK1 and JNK2 are ubiquitously distributed.
- By contrast, JNK3 is found mainly in neuronal tissue and testes.
Functions
JNK1 is involved in apoptosis, neurodegeneration, cell differentiation and proliferation, inflammatory conditions and cytokine production mediated by AP-1 (Activation Protein 1) such as RANTES, IL-8 and GM-CSF. [2]
Recently, JNK1 has been found to regulate Jun protein turnover by phosphorylation and activation of the ubiquitin ligase Itch.
JNKs can associate with scaffold proteins JNK Interacting Proteins as well as their upstream kinases JNKK1 and JNKK2 following their activation.
External links
References
- ↑ Waetzig V, Herdegen T (2005). "Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage". Br. J. Pharmacol 26 (9): 455-61. PMID 16054242.
- ↑ Oltmanns U, Issa R, Sukkar M, John M, Chung K (2003). "Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells". Br. J. Pharmacol. 139 (6): 1228-34. PMID 12871843.
Kinases: Serine/threonine-specific protein kinases (primarily EC 2.7.11) | |
|---|---|
| 2.7.11 | Pyruvate dehydrogenase kinase - Protein kinase A - Protein kinase G - Protein kinase C (Protein kinase Mζ) - Rhodopsin - Beta adrenergic receptor - G-protein coupled receptor kinases - Ca2+/calmodulin-dependent - Myosin light-chain) - Phosphorylase - Cyclin-dependent - Mitogen-activated (Extracellular signal-regulated, C-Jun N-terminal (MAPK8, MAPK9), P38 mitogen-activated protein) - MAP3K - GSK-3 - AMP-activated |
| 2.7.12 | MAP2K (1, 2, 3, 4, 5, 6, 7) |
| 2.7.1.37, or unknown | Anti-Mullerian hormone receptor - Ataxia telangiectasia mutated - Aurora (A, B) - Mammalian target of rapamycin - Bone morphogenetic protein receptors (1, 2) - CDKL5 - c-Raf - EIF-2 - Ribosomal s6 - Protein kinase B - PDK1 |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
